Stay updated on HER2/EGFR Mutant Tumors Clinical Trial
Sign up to get notified when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.

Latest updates to the HER2/EGFR Mutant Tumors Clinical Trial page
- Check3 days agoChange DetectedFooter now shows Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe Record History page shows a minor revision update in the footer, replacing Revision: v3.3.1 with Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check31 days agoChange DetectedThe history shows an addition: Revision: v3.3.1. It also removes the previous Revision: v3.2.0.SummaryDifference0.0%

- Check38 days agoChange DetectedThe general government funding operating-status notice at the top of the page was removed, which does not affect the study record content or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check53 days agoChange DetectedVisual refresh of the Record History page with updated layout and styling; no core study data, status, arms, enrollment, or outcomes appear changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedMajor update to the page content: a government-operating status notice and a new version tag (v3.2.0) replacing v3.1.0; no changes to pricing or availability information.SummaryDifference8%

Stay in the know with updates to HER2/EGFR Mutant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.